We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+11.75%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$65.7B
AUM Growth
+$6.62B
Cap. Flow
+$648M
Cap. Flow %
0.99%
Top 10 Hldgs %
27.2%
Holding
2,939
New
828
Increased
695
Reduced
744
Closed
553

Top Sells

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$400M
2
STZ icon
Constellation Brands
STZ
+$345M
3
META icon
Meta Platforms (Facebook)
META
+$286M
4
KVUE icon
Kenvue
KVUE
+$277M
5
ABBV icon
AbbVie
ABBV
+$258M

Sector Composition

Rank Sector Weight
1 Technology 16.4%
2 Healthcare 13.22%
3 Consumer Discretionary 12.71%
4 Financials 7.66%
5 Communication Services 7.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCHE icon
1451
Schwab Emerging Markets Equity ETF
SCHE
$12.3B
$1.55M ﹤0.01%
+61,225
New +$1.5M
QVCGA
1452
DELISTED
QVC Group Inc Series A
QVCGA
$1.54M ﹤0.01%
+25,090
New +$1.31M
ENB icon
1453
Enbridge
ENB
$121B
$1.54M ﹤0.01%
+42,549
New +$1.51M
NGNE icon
1454
Neurogene
NGNE
$663M
$1.54M ﹤0.01%
+30,218
New +$1.01M
MGRC icon
1455
McGrath RentCorp
MGRC
$2.95B
$1.53M ﹤0.01%
+12,400
New +$1.5M
SGRY icon
1456
Surgery Partners
SGRY
$2.04B
$1.53M ﹤0.01%
+51,228
New +$1.6M
INBX
1457
DELISTED
Inhibrx, Inc. Common Stock
INBX
$1.53M ﹤0.01%
+43,678
New +$1.59M
NRDS icon
1458
NerdWallet
NRDS
$630M
$1.52M ﹤0.01%
103,732
-69,716
-40% -$1.08M
DYN icon
1459
Dyne Therapeutics
DYN
$4.28B
$1.52M ﹤0.01%
+53,705
New +$1.21M
JILL icon
1460
J. Jill
JILL
$278M
$1.52M ﹤0.01%
+47,586
New +$1.21M
LOPE icon
1461
Grand Canyon Education
LOPE
$3.99B
$1.52M ﹤0.01%
11,150
+5,800
+108% +$757K
PARR icon
1462
Par Pacific Holdings
PARR
$3.97B
$1.52M ﹤0.01%
+40,966
New +$1.5M
TCRX icon
1463
TScan Therapeutics
TCRX
$50.6M
$1.52M ﹤0.01%
191,171
+80,620
+73% +$507K
DXC icon
1464
DXC Technology
DXC
$1.76B
$1.52M ﹤0.01%
+71,525
New +$1.56M
SGML icon
1465
Sigma Lithium
SGML
$1.06B
$1.52M ﹤0.01%
117,011
+36,098
+45% +$645K
NOAH
1466
Noah Holdings
NOAH
$594M
$1.51M ﹤0.01%
132,184
+89,930
+213% +$1.04M
GPCR icon
1467
Structure Therapeutics
GPCR
$3.4B
$1.51M ﹤0.01%
35,241
-70,529
-67% -$2.97M
KCGI.WS
1468
CALL
DELISTED
Kensington Capital Acquisition Corp. V Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
KCGI.WS
$1.5M ﹤0.01%
137,244
-32,756
-19% -$2.14K
ZLSWW
1469
CALL
DELISTED
Zalatoris II Acquisition Corp Warrant
ZLSWW
$1.5M ﹤0.01%
137,552
TGAN
1470
DELISTED
Transphorm, Inc. Common Stock
TGAN
$1.49M ﹤0.01%
+304,300
New +$1.44M
WLDN icon
1471
Willdan Group
WLDN
$1.06B
$1.48M ﹤0.01%
51,101
+18,878
+59% +$411K
DSKE
1472
DELISTED
Daseke, Inc. Common Stock
DSKE
$1.48M ﹤0.01%
+178,400
New +$1.46M
RIOT icon
1473
Riot Platforms
RIOT
$8.03B
$1.48M ﹤0.01%
120,763
-1,860,292
-94% -$24.2M
KN icon
1474
Knowles
KN
$3.07B
$1.47M ﹤0.01%
+91,410
New +$1.5M
UWMC.WS
1475
CALL
DELISTED
UWM Holdings Warrants
UWMC.WS
$1.47M ﹤0.01%
200,000

Similar funds

Marshall Wace's Q1 2024 Portfolio in Review

As of Q1 2024, Marshall Wace held 2,939 positions worth $65.7B, up 11% from $59B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Marshall Wace's Q1 2024 filing shows 828 new, 695 increased, 744 reduced and 553 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 900,000 shares worth $433M. The largest sale was Walmart Inc, an estimated $400M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Marshall Wace's largest Q1 2024 buy was Vanguard S&P 500 ETF: 900,000 shares worth $433M.
  • Marshall Wace added most to Goldman Sachs in Q1 2024, an estimated $374M increase.
  • Marshall Wace's biggest Q1 2024 reduction was Walmart Inc, cutting an estimated $400M.
  • Marshall Wace fully exited Celsius Holdings in Q1 2024, selling an estimated $143M.
  • Marshall Wace's ten largest holdings make up 27% of its $65.7B portfolio in Q1 2024.
  • Marshall Wace opened 828 new positions and closed 553 in Q1 2024.
  • Marshall Wace's portfolio value rose 11% quarter-over-quarter to $65.7B.

Based on Marshall Wace's 13F filing for Q1 2024, filed 15 May 2024.